Up to 30 Percent of CVD Mortality Attributable to Excess Salt Intake
By Elana Gotkine HealthDay Reporter
FRIDAY, March 29, 2024 -- Excess sodium intake is associated with 10 to 30 percent of cardiovascular disease (CVD) mortality, according to a study published online March 26 in JAMA Network Open.
Hyung-Suk Yoon, Ph.D., M.P.H., from the Vanderbilt University School of Medicine in Nashville, Tennessee, and colleagues examined the associations of excessive dietary sodium with all-cause and cause-specific mortality among predominantly low-income Black and White Americans in a cohort study including 64,329 participants aged 40 to 79 years recruited from 12 Southeastern states from 2002 to 2009.
The researchers found that mean dietary sodium intake was 4,512 and 4,041 mg/day in Black and White individuals, respectively; 81.2 and 79.5 percent of Black and White individuals, respectively, exceeded the current dietary recommendations of 2,300 mg/day. A total of 17,811 deaths were documented during a median follow-up of 13.8 years, including 5,701 from CVD. The hazard ratios per 1,000-mg increase in daily sodium intake were 1.07 and 1.08 for deaths from total CVD and coronary heart disease (CHD), respectively, in Black individuals, and 1.08 and 1.13, respectively, in White individuals, after adjustment for potential confounders. There were no significant associations seen for cancer mortality. Sodium intake above the recommended threshold may account for 10, 13, and 30 percent of total CVD, CHD, and heart failure deaths, respectively, in this low-income Southern population in population-attributable risk estimates.
"Developing effective dietary modification strategies tailored to this marginalized population is urgently needed to promote health and prevent ever-increasing health disparities in the United States," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
High Level of Approval Observed for Polygenic Embryo Screening
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...
Andexanet Yields Better Control of Hematoma Expansion Than Usual Care
FRIDAY, May 17, 2024 -- For patients who had taken factor Xa inhibitors within 15 hours before having an acute intracerebral hemorrhage, andexanet alfa, which reverses the effects...
AI Chatbots Can Generate Quality, Empathetic, Readable Responses
FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.